Guide for Authors
Clinical
Biochemistry publishes articles relating to clinical chemistry, molecular biology and genetics, therapeutic drug monitoring and
toxicology, laboratory immunology and laboratory medicine in general, with the focus on analytical and clinical investigation of laboratory
tests in humans used for diagnosis, prognosis, treatment and therapy, and monitoring of disease.
Manuscripts are categorized as Analytical
or Clinical Investigations and may be offered as Full Papers, Short Communications, or Letters. Opinion pieces and Special Reports are
welcome, but contributors are encouraged to contact the Editor-in-Chief to avoid conflict with other forthcoming publications.
Types of submission and criteria
-
Original Research Communications (designated as one of two
categories: Analytical or Clinical Investigation) may be offered as Full Papers or as Short Communications.
The latter format is recommended for presenting technical evaluations and short clinical notes, comprising up to 1,500 words of text,
10 references, and two illustrative items (Tables and/or Figures).
-
Case Reports will be accepted only where they provide
novel insight into disease mechanisms or diagnostic applications.
-
Reviews will be welcome but prospective authors are
strongly advised to seek authorization from the Editor-in-Chief to avoid conflict with scheduled reviews invited by the Editorial Board.
They should address new topics or trends in clinical biochemistry or related fields.
-
Consensus recommendations or guidelines
on the use of laboratory test for clinical practice will be considered if they are compiled by a recognized organization or expert panel
(e;g. IFCC, IUPAC, AACC, etc.) Please contact the Editor-in-Chief for consideration. The responsibility for such material remains with
the originating body.
Contact details for submission
Papers should be submitted
using the
Clinical Biochemistry online submission system,
http://ees.elsevier.com/clb.
Page
charges
This journal has no page charges.
Ethics
in publishing
For information on Ethics in publishing and Ethical guidelines for journal publication see
http://www.elsevier.com/publishingethics
and
http://www.elsevier.com/ethicalguidelines.
Policy and ethics
The work
described in your article must have been carried out in accordance with
The Code of Ethics of the World Medical Association (Declaration
of Helsinki) for experiments involving humans 
http://www.wma.net/e/policy/b3.htm;
Uniform Requirements for
manuscripts submitted to Biomedical journals http://www.icmje.org, published by the International Committee of Medical
Journal Editors.
This must be stated at an appropriate point in the article
Please note: Clinical Biochemistry does
not accept submission of papers based on animal studies.
STARD initiative
Clinical Biochemistry supports
the STARD initiative on reporting of diagnostic accuracy.
http://www.stard-statement.org
Conflict
of interest
All authors are requested to disclose any actual or potential conflict of interest including any financial,
personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately
influence, or be perceived to influence, their work. See also
http://www.elsevier.com/conflictsofinterest.
Submission declaration and verification
Submission of an article implies that the work described has not been
published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration
for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where
the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language,
including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the
originality detection software iThenticate. See also
http://www.elsevier.com/editors/plagdetect.
Authorship
All
authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition
of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content,
(3) final approval of the version to be submitted.
Changes to authorship
This policy concerns
the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:
Before the accepted manuscript
is published in an online issue: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal
Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed,
or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition,
removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must
follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2)
publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.
After the accepted manuscript
is published in an online issue: Any requests to add, delete, or rearrange author names in an article published in an online issue
will follow the same policies as noted above and result in a corrigendum.
Copyright
Upon
acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright
see
http://www.elsevier.com/copyright). Acceptance of the agreement will ensure the widest possible dissemination of information.
An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement'
form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles
including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution
outside the institution and for all other derivative works, including compilations and translations (please consult
http://www.elsevier.com/permissions).
If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit
the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult
http://www.elsevier.com/permissions.
Retained author rights
As an author you (or your employer or institution) retain certain rights; for details
you are referred to:
http://www.elsevier.com/authorsrights.
Role of the funding source
You
are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly
describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing
of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this
should be stated. Please see
http://www.elsevier.com/funding.
Funding body agreements and
policies
Elsevier has established agreements and developed policies to allow authors whose articles appear in journals
published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To
learn more about existing agreements and policies please visit
http://www.elsevier.com/fundingbodies.
Elsevier journals comply with current NIH public access policy.
Open access
This
journal offers you the option of making your article freely available to all via the ScienceDirect platform. To prevent any conflict
of interest, you can only make this choice after receiving notification that your article has been accepted for publication. The fee
of $3,000 excludes taxes and other potential author fees such as color charges. In some cases, institutions and funding bodies have entered
into agreement with Elsevier to meet these fees on behalf of their authors. Details of these agreements are available at
http://www.elsevier.com/fundingbodies.
Authors of accepted articles, who wish to take advantage of this option, should complete and submit the order form (available at
http://www.elsevier.com/locate/openaccessform.pdf).
Whatever access option you choose, you retain many rights as an author, including the right to post a revised personal version of your
article on your own website. More information can be found here:
http://www.elsevier.com/authorsrights.
Language and language services
Please write your text in good English (American or British usage is accepted,
but not a mixture of these). Authors who require information about language editing and copyediting services pre- and post-submission
please visit
http://webshop.elsevier.com/languageservices
or our customer support site at
http://support.elsevier.com
for more information.
Submission
Submission to this journal proceeds totally online and
you will be guided stepwise through the creation and uploading of your files. The system automatically converts source files to a single
PDF file of the article, which is used in the peer-review process. Please note that even though manuscript source files are converted
to PDF files at submission for the review process, these source files are needed for further processing after acceptance. All correspondence,
including notification of the Editor's decision and requests for revision, takes place by e-mail removing the need for a paper trail.
Referees
A minimum of six suitable potential reviewers (please provide their name, email addresses, and institutional
affiliation). When compiling this list of potential reviewers please consider the following important criteria: they must be knowledgeable
about the manuscript subject area; must not be from your own institution; at least two of the suggested reviewers should be from another
country than the authors'; and they should not have recent (less than four years) joint publications with any of the authors. However,
the final choice of reviewers is at the editors' discretion.
Types of submission and criteria
•
Original Research
Communications (designated as one of two categories:
Analytical or
Clinical Investigation) may be offered as
Full
Papers or as
Short Communications. The latter format is recommended for presenting technical evaluations and short clinical
notes, comprising up to 1,500 words of text, 10 references, and two illustrative items (Tables and/or Figures).
•
Case Reports
will be accepted only where they provide novel insight into disease mechanisms or diagnostic applications.
•
Critical Reviews
will be welcome but prospective authors are strongly advised to seek authorization from the Editor-in-Chief to avoid conflict with scheduled
reviews invited by the Editorial Board. They should address new topics or trends in clinical biochemistry or related fields.
•
Consensus recommendations or guidelines on the use of laboratory test for clinical practice will be considered if they are compiled
by a recognized organization or expert panel (e.g. IFCC, IUPAC, AACC, etc). Please contact the Editor-in-Chief for consideration. The
responsibility for such material remains with the originating body.
Use
of wordprocessing software
It is important that the file be saved in the native format of the wordprocessor used. The text
should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced
on processing the article. In particular, do not use the wordprocessor's options to justify text or to hyphenate words. However, do use
bold face, italics, subscripts, superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each individual
table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared
in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier:
http://www.elsevier.com/guidepublication).
Note that source files of figures, tables and text graphics will be required whether or not you embed your figures in the text. See also
the section on Electronic artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check'
functions of your wordprocessor.
Subdivision - numbered sections
Divide your article into
clearly defined and numbered sections. Subsections should be numbered 1.1 (then 1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included
in section numbering). Use this numbering also for internal cross-referencing: do not just refer to 'the text'. Any subsection may be
given a brief heading. Each heading should appear on its own separate line.
Introduction
State
the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.
Material and methods
Provide sufficient detail to allow the work to be reproduced, with details of supplier
and catalogue number when appropriate. Methods already published should be indicated by a reference: only relevant modifications should
be described.
Patients
If human subjects were used in the experiment please make a statement to the effect that this
study has been cleared by your Institution Ethics Review Board for human studies and that patients have signed an informed consent. These
are required by standards.
Experimental
Provide sufficient detail to allow the work to be
reproduced. Methods already published should be indicated by a reference: only relevant modifications should be described.
Results
Results should be clear and concise.
Discussion
This
should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate.
Avoid extensive citations and discussion of published literature.
Conclusions
The main conclusions
of the study may be presented in a short Conclusions section, which may stand alone or form a subsection of a Discussion or Results and
Discussion section.
Glossary
Please supply, as a separate list, the definitions of field-specific
terms used in your article.
Appendices
If there is more than one appendix, they should be
identified as A, B, etc. Formulae and equations in appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent
appendix, Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc.
Essential title
page information
•
Title.
Concise and informative. Titles are often used in information-retrieval
systems. Avoid abbreviations and formulae where possible.
•
Author names and affiliations.
Where the family name
may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work
was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in
front of the appropriate address. Provide the full postal address of each affiliation, including the country name and, if available,
the e-mail address of each author.
•
Corresponding author.
Clearly indicate who will handle correspondence at
all stages of refereeing and publication, also post-publication.
Ensure that telephone and fax numbers (with country and area code)
are provided in addition to the e-mail address and the complete postal address. Contact details must be kept up to date by the corresponding
author.
•
Present/permanent address.
If an author has moved since the work described in the article was done,
or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address
at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for
such footnotes.
Abstract
A concise and factual abstract is required. The abstract should
state briefly the purpose of the research, the principal results and major conclusions. An abstract is often presented separately from
the article, so it must be able to stand alone. For this reason, References should be avoided, but if essential, then cite the author(s)
and year(s). Also, non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention
in the abstract itself.
Page 2 of the typescript should be reserved for the abstract which should be presented
in a structured format and should not exceed 250 words. The following headings should be included followed by a colon: a) Objectives:
b) Design and Methods: c) Results: d) Conclusions.
Maximum length of submissions
Full length
articles should not exceed 4000 words (maximum 40 references), and up to 6 tables and/or figures with short communications comprising
up to 1500 words of text, maximum 15 references, and two illustrative items (Tables and/or Figures). Letters will be classified as Case
Reports (provide novel insight into disease mechanisms or diagnostic applications). Laboratory Notes (technical evaluation or important
insight into analytical methodology), or Letters to the Editor (focused on a specific article that has appeared in Clinical Biochemistry
within 4 weeks of print issue date of article). For all 3 types of letters listed above, the text should not exceed 500 words, with no
abstract, a maximum of 1 table or figure and up to 5 references. Review Articles and Special Reports may exceed the word and reference
limit for Full length articles as per the comprehensive nature of these articles. However, both of these articles (Reviews and Special
Reports) will still require an abstract (unstructured, 250 word maximum). Editorials and Opinion pieces will not require an abstract
and will be limited to 2000 words and up to 20 references.
Graphical abstract
A Graphical
abstract is optional and should summarize the contents of the article in a concise, pictorial form designed to capture the attention
of a wide readership online. Authors must provide images that clearly represent the work described in the article. Graphical abstracts
should be submitted as a separate file in the online submission system. Image size: Please provide an image with a minimum of 531 ×
1328 pixels (h × w) or proportionally more. The image should be readable at a size of 5 × 13 cm using a regular screen resolution
of 96 dpi. Preferred file types: TIFF, EPS, PDF or MS Office files. See
http://www.elsevier.com/graphicalabstracts for examples.
Authors can make use of Elsevier's Illustration and Enhancement service to ensure the best presentation of their images also in accordance
with all technical requirements:
Illustration
Service.
Highlights
Highlights are mandatory for this journal. They consist
of a short collection of bullet points that convey the core findings of the article and should be submitted in a separate file in the
online submission system. Please use 'Highlights' in the file name and include 3 to 5 bullet points (maximum 85 characters, including
spaces, per bullet point). See
http://www.elsevier.com/highlights for examples.
Keywords
Immediately
after the abstract, provide a maximum of 10 keywords for full papers, or 5 keywords for Short Communications, using American spelling
and avoiding general and plural terms and multiple concepts (avoid, for example, "and", "of"). Please use terms from the most current
issue of medical subject headings of
Index Medicus. The key words should cover precisely the contents of the submitted paper
and should give readers sufficient information as to the relevance of the paper to his/her particular field. Be sparing with abbreviations:
only abbreviations firmly established in the field may be eligible. These keywords will be used for indexing purposes.
Abbreviations
Define abbreviations that are not standard in this field in a footnote to be placed on the first
page of the article. Such abbreviations that are unavoidable in the abstract must be defined at their first mention there, as well as
in the footnote. Ensure consistency of abbreviations throughout the article.
Acknowledgements
Collate
acknowledgements in a separate section at the end of the article before the references and do not, therefore, include them on the title
page, as a footnote to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language
help, writing assistance or proof reading the article, etc.).
Database linking
Elsevier
aims at connecting online articles with external databases which are useful in their respective research communities. If your article
contains relevant unique identifiers or accession numbers (bioinformatics) linking to information on entities (genes, proteins, diseases,
etc.) or structures deposited in public databases, then please indicate those entities according to the standard explained below.
Authors
should explicitly mention the
database abbreviation (as mentioned below) together with the actual database number, bearing in
mind that an error in a letter or number can result in a dead link in the online version of the article.
Please use the following
format:
Database ID: xxxx
Links can be provided in your online article to the following databases (examples of citations are
given in parentheses):
•
ASTM: ASTM Standards Database (ASTM ID: G63)
•
CCDC: Cambridge Crystallographic Data Centre (CCDC ID: AI631510)
•
GenBank: Genetic sequence database at the National Center for
Biotechnology Information (NCBI) (GenBank ID: BA123456)
•
GEO:
Gene Expression Omnibus (GEO ID: GSE27196; GEO ID: GPL5366; GEO ID: GSM9853)
•
MI:
EMBL-EBI OLS Molecular Interaction Ontology (MI ID: 0218)
•
MINT:
Molecular INTeractions database (MINT ID: 6166710)
•
NCBI Taxonomy:
NCBI Taxonomy Browser (NCBI Taxonomy ID: 48184)
•
NCT: ClinicalTrials.gov
(NCT ID: NCT00222573)
•
OMIM: Online Mendelian Inheritance
in Man (OMIM ID: 601240)
•
PDB: Worldwide Protein Data
Bank (PDB ID: 1TUP)
•
TAIR: The Arabidopsis Information Resource
database (TAIR ID: AT1G01020)
•
UniProt: Universal Protein Resource
Knowledgebase (UniProt ID: Q9H0H5)
Footnotes
Footnotes should be used sparingly. Number
them consecutively throughout the article, using superscript Arabic numbers. Many wordprocessors build footnotes into the text, and this
feature may be used. Should this not be the case, indicate the position of footnotes in the text and present the footnotes themselves
separately at the end of the article. Do not include footnotes in the Reference list.
Table footnotes
Indicate each
footnote in a table with a superscript lowercase letter.
Artwork
Electronic
artwork
General points
• Make sure you use uniform lettering and sizing of your original artwork.
•
Save text in illustrations as 'graphics' or enclose the font.
• Only use the following fonts in your illustrations: Arial, Courier,
Times, Symbol.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention
for your artwork files.
• Provide captions to illustrations separately.
• Produce images near to the desired size of
the printed version.
• Submit each figure as a separate file.
A detailed guide on electronic artwork is available on our
website:
http://www.elsevier.com/artworkinstructions
You are urged to visit this site; some excerpts from the
detailed information are given here.
Formats
Regardless of the application used, when your electronic artwork is
finalised, please 'save as' or convert the images to one of the following formats (note the resolution requirements for line drawings,
halftones, and line/halftone combinations given below):
EPS: Vector drawings. Embed the font or save the text as 'graphics'.
TIFF:
Color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000
dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.
If your electronic artwork
is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 'as is'.
Please do not:
•
Supply files that are optimised for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too low;
• Supply files that are
too low in resolution;
• Submit graphics that are disproportionately large for the content.
Color
artwork
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct
resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure, at no additional charge,
that these figures will appear in color on the Web (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations
are reproduced in color in the printed version.
For color reproduction in print, you will receive information regarding the costs
from Elsevier after receipt of your accepted article. Please indicate your preference for color: in print or on the Web only. For
further information on the preparation of electronic artwork, please see
http://www.elsevier.com/artworkinstructions.
Please
note: Because of technical complications which can arise by converting color figures to 'gray scale' (for the printed version should
you not opt for color in print) please submit in addition usable black and white versions of all the color illustrations.
Figure captions
Ensure that each illustration has a caption. Supply captions separately, not attached to the
figure. A caption should comprise a brief title (
not on the figure itself) and a description of the illustration. Keep text in
the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Tables
Number
tables consecutively in accordance with their appearance in the text. Place footnotes to tables below the table body and indicate them
with superscript lowercase letters. Avoid vertical rules. Be sparing in the use of tables and ensure that the data presented in tables
do not duplicate results described elsewhere in the article.
The Editor-in-Chief, on accepting a manuscript,
may recommend that additional tables containing important backup data, too extensive to be published in the article, may be published
as supplementary material (see below) or deposited with the National Auxiliary Publications Service or made available by the author(s).
In that event, an appropriate statement will be added to the text. Submit such tables for consideration with the manuscript.
References
Citation in text
Please ensure that every reference cited in the
text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full. Unpublished
results and personal communications are not recommended in the reference list, but may be mentioned in the text. If these references
are included in the reference list they should follow the standard reference style of the journal and should include a substitution of
the publication date with either 'Unpublished results' or 'Personal communication'. Citation of a reference as 'in press' implies that
the item has been accepted for publication and a copy of the title page of the relevant article must be submitted.
Web references
As a minimum, the full URL should be given and the date when the reference was last accessed.
Any further information, if known (DOI, author names, dates, reference to a source publication, etc.), should also be given. Web references
can be listed separately (e.g., after the reference list) under a different heading if desired, or can be included in the reference list.
References in a special issue
Please ensure that the words 'this issue' are added to any references in the
list (and any citations in the text) to other articles in the same Special Issue.
Reference management
software
This journal has standard templates available in key reference management packages EndNote (
http://www.endnote.com/support/enstyles.asp)
and Reference Manager (
http://refman.com/support/rmstyles.asp). Using plug-ins to wordprocessing packages, authors only
need to select the appropriate journal template when preparing their article and the list of references and citations to these will be
formatted according to the journal style which is described below.
Reference style
Text:
Indicate references by number(s) in square brackets in line with the text. The actual authors can be referred to, but the reference number(s)
must always be given.
Example: '..... as demonstrated [3,6]. Barnaby and Jones [8] obtained a different result ....'
List:
Number the references (numbers in square brackets) in the list in the order in which they appear in the text.
Examples:
Reference to a journal publication:
[1] J. van der Geer, J.A.J. Hanraads, R.A. Lupton, The art of writing a scientific article,
J. Sci. Commun. 163 (2010) 51–59.
Reference to a book:
[2] W. Strunk Jr., E.B. White, The Elements of Style, fourth ed.,
Longman, New York, 2000.
Reference to a chapter in an edited book:
[3] G.R. Mettam, L.B. Adams, How to prepare an electronic
version of your article, in: B.S. Jones, R.Z. Smith (Eds.), Introduction to the Electronic Age, E-Publishing Inc., New York, 2009, pp.
281–304.
Journal abbreviations source
Journal names should be abbreviated according
to
Index Medicus journal abbreviations:
http://www.nlm.nih.gov/tsd/serials/lji.html;
List of title word abbreviations:
http://www.issn.org/2-22661-LTWA-online.php;
CAS (Chemical Abstracts Service):
http://www.cas.org/sent.html.
Abbreviations and units
Standard abbreviations as listed in the
Council of Biology Editors Style Manual
may be used without definition. Use non-standard abbreviations sparingly, preceding their first use in the text with the corresponding
full designation. Use units in conformity with the standard International System (SI) of units.
Video
data
Elsevier accepts video material and animation sequences to support and enhance your scientific research. Authors who
have video or animation files that they wish to submit with their article are strongly encouraged to include these within the body of
the article. This can be done in the same way as a figure or table by referring to the video or animation content and noting in the body
text where it should be placed. All submitted files should be properly labeled so that they directly relate to the video file's content.
In order to ensure that your video or animation material is directly usable, please provide the files in one of our recommended file
formats with a preferred maximum size of 50 MB. Video and animation files supplied will be published online in the electronic version
of your article in Elsevier Web products, including ScienceDirect:
http://www.sciencedirect.com. Please supply 'stills'
with your files: you can choose any frame from the video or animation or make a separate image. These will be used instead of standard
icons and will personalize the link to your video data. For more detailed instructions please visit our video instruction pages at
http://www.elsevier.com/artworkinstructions.
Note: since video and animation cannot be embedded in the print version of the journal, please provide text for both the electronic and
the print version for the portions of the article that refer to this content.
Supplementary data
Elsevier
accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer the author additional
possibilities to publish supporting applications, high-resolution images, background datasets, sound clips and more. Supplementary files
supplied will be published online alongside the electronic version of your article in Elsevier Web products, including ScienceDirect:
http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable, please provide the data
in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply
a concise and descriptive caption for each file. For more detailed instructions please visit our artwork instruction pages at
http://www.elsevier.com/artworkinstructions.
Supplementary material captions
Each supplementary material file should have a short caption which will be
placed at the bottom of the article, where it can assist the reader and also be used by search engines.
Submission
checklist
The following list will be useful during the final checking of an article prior to sending it to the journal
for review. Please consult this Guide for Authors for further details of any item.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal
address
• Telephone and fax numbers
All necessary files have been uploaded, and contain:
• Keywords
•
All figure captions
• All tables (including title, description, footnotes)
Further considerations
• Manuscript
has been 'spell-checked' and 'grammar-checked'
• References are in the correct format for this journal
• All references
mentioned in the Reference list are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted
material from other sources (including the Web)
• Color figures are clearly marked as being intended for color reproduction
on the Web (free of charge) and in print, or to be reproduced in color on the Web (free of charge) and in black-and-white in print
•
If only color on the Web is required, black-and-white versions of the figures are also supplied for printing purposes
For any further
information please visit our customer support site at
http://support.elsevier.com.
Use of the Digital Object Identifier
The
Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character
string which is assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore,
it is an ideal medium for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic
information. The correct format for citing a DOI is shown as follows (example taken from a document in the journal
Physics Letters
B):
doi:10.1016/j.physletb.2010.09.059
When you use the DOI to create URL hyperlinks to documents on the web, the DOIs are
guaranteed never to change.
Proofs
One set of page proofs (as PDF files) will be sent by
e-mail to the corresponding author (if we do not have an e-mail address then paper proofs will be sent by post) or, a link will be provided
in the e-mail so that authors can download the files themselves. Elsevier now provides authors with PDF proofs which can be annotated;
for this you will need to download Adobe Reader version 7 (or higher) available free from
http://get.adobe.com/reader. Instructions
on how to annotate PDF files will accompany the proofs (also given online). The exact system requirements are given at the Adobe site:
http://www.adobe.com/products/reader/tech-specs.html.
If you do not wish to use the PDF annotations function, you may
list the corrections (including replies to the Query Form) and return them to Elsevier in an e-mail. Please list your corrections quoting
line number. If, for any reason, this is not possible, then mark the corrections and any other comments (including replies to the Query
Form) on a printout of your proof and return by fax, or scan the pages and e-mail, or by post. Please use this proof only for checking
the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted
for publication will only be considered at this stage with permission from the Editor. We will do everything possible to get your article
published quickly and accurately – please let us have all your corrections within 48 hours. It is important to ensure that all
corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent corrections
cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of your article
if no response is received.
Offprints
The corresponding author, at no cost, will be provided
with a PDF file of the article via e-mail. For an extra charge, paper offprints can be ordered via the offprint order form which is sent
once the article is accepted for publication. The PDF file is a watermarked version of the published article and includes a cover sheet
with the journal cover image and a disclaimer outlining the terms and conditions of use.
For
inquiries relating to the submission of articles (including electronic submission) please visit this journal's homepage. Contact details
for questions arising after acceptance of an article, especially those relating to proofs, will be provided by the publisher. You can
track accepted articles at
http://www.elsevier.com/trackarticle. You can also check our Author FAQs (
http://www.elsevier.com/authorFAQ)
and/or contact Customer Support via
http://support.elsevier.com.
